First AD

Second AD

The management of lung cancer brain metastases has seen significant advancements, with a focus on personalized treatment strategies. The integration of targeted therapies and immunotherapies has improved patient outcomes, offering new hope for those affected. Stereotactic radiosurgery and whole-brain radiation therapy remain critical components of treatment, but their roles are evolving with the advent of novel systemic therapies. Multidisciplinary collaboration is essential for optimizing treatment plans, ensuring that patients receive the most effective and individualized care. Ongoing research continues to refine these approaches, aiming to further enhance survival and quality of life.

Pharmaceutical Commerce - August 2025

View the Pharmaceutical Commerce August 2025 issue in an interactive format.

Pharmaceutical Commerce: August 2025 Interactive Digital Edition